HOPE
Annie Moisan, PhD. Annie’s expertise is in the mechanistic biology of drug targets and preclinical safety strategies of novel therapeutics. She has worked at Idorsia Pharmaceuticals, Roche Innovation Center Basel, and as a postdoctoral fellow in genetics and stem cell biology at Harvard Medical School.…